Investments

The medium/long-term financing needs of Italian small-mid caps can be adequately met thanks to the flexibility of our investment policy.

In just a few month the Anima Alternative 1 Funds has completed investments as part of major structured finance operations.



Ceme S.p.A.
Ceme S.p.A.

The Ceme Group engages in the production of fluid control solutions – including primarily solenoid valves and pumps – for a wide range of industrial and consumer applications. Its main channels of trade include the single-serve and professional coffee industry and the ironing and steam cleaning system sector.

Investment date: April 2021

+
Gnutti Cirillo S.p.A.
Gnutti Cirillo S.p.A.

The Gnutti Cirillo Group engages in hot pressing and mechanical processing of brass and other non-ferrous metals, with applications in industrial and HVAC, plumbing and sanitary fitting sectors.

Investment date: May 2021

+
Jakala S.p.A.
Jakala S.p.A.

Jakala S.p.A. operates in the B2B landscape with a focus on sales&marketing, providing loyalty&engagement and advisory&marketing solutions.

Investment date: July 2021

+
Bianalisi S.p.A.
Bianalisi S.p.A.

The Bianalisi Group engages in the management of laboratories, outpatient clinics, imaging medical centres, radiology facilities and specialist practices. 

Investment date: September 2021

+
W Group
W Group

W Group is an Italian group specialized in human resources, agency work, personnel selection and training.

 

Investment date: October 2021

+
Formula Impresoft S.p.A.
Formula Impresoft S.p.A.

The Impresoft Group delivers IT services by providing support and advice in choosing the best technologies and solutions available in the ERP, MES, CRM, CPM and datacenter landscape, while offering a full range of services and products related to digital transformation.

Investment date: April 2022

+
Neopharmed Gentili S.p.A.
Neopharmed Gentili S.p.A.

Neopharmed Gentili is an Italian pharmaceutical company, specialized in the commercialization of primary care solutions for numerous therapeutic areas.

Investment date: May 2022

+